PPLPHARMA — Piramal Pharma (Mumbai) Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹253.37bn
- IN₹88.69bn
Brief: Piramal Pharma Solutions Announces Partnership With Botanix To Support Drug Substance Development
Brief: Piramal Pharma Announces Successful Closure Of Us FDA Inspection At Digwal Facility
India's Piramal Pharma eyes complex drug demand for earnings boost, chair says
Brief: Piramal Pharma Says Closure Of US FDA Inspection At Manufacturing Facility At Lexington
Brief: Piramal Pharma Says GPCB Imposed Interim Environmental Damage Compensation Of 10 Million Rupees
Brief: Piramal Pharma Introduces Tablet-In-Capsule Capabilities
Indian contract drug makers to gain global share, says HDFC Securities
Brief: Piramal Pharma Says US FDA Issued A Form-483, With Four Observations
Brief: Piramal Pharma Solutions Achieves Regulatory Compliance For Nitrosamine Impurities
Brief: Piramal Pharma Sept Quarter Consol Net Loss 992.2 Million Rupees
Brief: Piramal Pharma, Newamsterdam Pharma Invest To Enhance Oral Solid Dosage Capabilities
Brief: Piramal Pharma Reports Fire At Third-Party Warehouse In Telangana
Brief: Piramal Pharma Approves Sale Of Unit For 85 Million Rupees
Brief: Piramal Pharma Unit Receives $2.4 Mln In Settlement From Astral
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Brief: Carlyle Group May Sell Up To 10% Stake In India's Piramal Pharma Via Block Deals, Moneycontrol reports
Carlyle to sell up to 10% stake in Piramal Pharma, Moneycontrol reports (updated)
Carlyle to sell up to 10% stake in Piramal Pharma, Moneycontrol reports